Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477

A Laboratory manual

Ashburner, M. (1989) · Cold Spring Harbor Laboratory eBooks · Cited by 6,756

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379

Antibodies: A laboratory manual

J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,141

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint

Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,208

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Polyák, K., Lee, M.-H., Erdjument‐Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118

pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950

New functional activities for the p21 family of CDK inhibitors.

LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402

The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K. M., Hara, E., Vousden, K. H., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,178

Inhibition of cyclin-dependent kinases by p21.

Harper, J., Elledge, S., Keyomarsi, K., Dynlacht, B., Tsai, L., Zhang, P.-M., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,111

Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,077

D-Type Cyclin-Dependent Kinase Activity in Mammalian Cells

Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,067

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010

Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts

Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.Preprint

Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952

The p16INK4a/CDKN2A tumor suppressor and its relatives

Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899

Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 899

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Preprint

Lee, M., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889

Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Meyerson, M. M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 799

p53 Functions as a Cell Cycle Control Protein in Osteosarcomas

Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M. C., Bressac, B., Öztürk, M., Baker, S. J., Vogelstein, B., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 775

Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence

Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Preprint

Guan, K., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 707

Novel INK4 Proteins, p19 and p18, Are Specific Inhibitors of the Cyclin D-Dependent Kinases CDK4 and CDK6

Hirai, H., Roussel, M. F., Kato, J., Ashmun, R. A., & Sherr, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2672 · Cited by 647

The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2.

Kitagawa, M., Higashi, H., Jung, H. K., Suzuki‐Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01097.x · Cited by 596

Mutations and altered expression of p16INK4 in human cancer.

Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B. I., Serrano, M., & Beach, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11045 · Cited by 541

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

Stepanova, L., Leng, X., Parker, S. B., & Harper, J. W. (1996) · Genes & Development · doi:10.1101/gad.10.12.1491 · Cited by 483

Growth suppression by p16ink4 requires functional retinoblastoma protein

Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433

Deletion of p16 and p15 genes in brain tumors.

Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404

Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4

Serrano, M., Gómez-Lahoz, E., DePinho, R. A., Beach, D., & Bar‐Sagi, D. (1995) · Science · doi:10.1126/science.7809631 · Cited by 373

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.

Zhang, H., Xiong, Y., & Beach, D. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.897 · Cited by 361

Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

Parry, D., Bates, S., Mann, D. J., & Peters, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07026.x · Cited by 354

Identification of Human and Mouse p19, a Novel CDK4 and CDK6 Inhibitor with Homology to p16ink4

Chan, F. K. M., Zhang, J., Cheng, L. E., Shapiro, D. N., & Winoto, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2682 · Cited by 339

The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.Preprint

Reynisdóttir, I., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.4.492 · Cited by 332

Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1

Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320

Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts.

McConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314

Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes.

Dulić, V, Drullinger, L. F., Lees, E., Reed, S. I., & Stein, G. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11034 · Cited by 279

Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4

Blain, S. W., Montalvo, E., & Massagué, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25863 · Cited by 279

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Bates, S., Bonetta, L. P., MacAllan, D., Parry, D., Holder, A. A., Dickson, C., & Peters, G. (1994) · PubMed · Cited by 260

Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.Preprint

Hatakeyama, M., Brill, J. A., Fink, G. R., & Weinberg, R. A. (1994) · Genes & Development · doi:10.1101/gad.8.15.1759 · Cited by 250

Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes.

Steiner, P., Philipp, A., Lukáš, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bártek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246

Formation of p27-CDK complexes during the human mitotic cell cycle.

Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. M., & Koff, A. (1996) · PubMed · Cited by 238

Mutation and altered expression of p16^ in human cancer

Okamoto, A. (1994) · Proceedings of the National Academy of Sciences · Cited by 234

Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.

Poon, R. Y. C., Toyoshima, H., & Hunter, T. R. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.9.1197 · Cited by 230

Transforming Growth Factor β Stabilizes p15 INK4B Protein, Increases p15 INK4B -cdk4 Complexes, and Inhibits Cyclin D1-cdk4 Association in Human Mammary Epithelial Cells

Sandhu, C., Garbe, J. C., Bhattacharya, N., Daksis, J. I., Pan, C., Yaswen, P., Koh, J., Slingerland, J. M., & Stampfer, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2458 · Cited by 195

Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

Shapiro, G. I., Park, J. E., Edwards, C. D., Mao, L., Merlo, A. U., Sidransky, D., Ewen, M. E., & Rollins, B. J. (1995) · PubMed · Cited by 181

Untitled work

(1996) · PubMed · Cited by 180

Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.

Nakanishi, M., Robetorye, R. S., Adami, G. R., Pereira‐Smith, O. M., & Smith, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07031.x · Cited by 179

Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.

Hall, M., Bates, S., & Peters, G. J. (1995) · PubMed · Cited by 178

Tumor Suppressor p16INK4A: Determination of Solution Structure and Analyses of Its Interaction with Cyclin-Dependent Kinase 4

Byeon, I. L., Li, J., Ericson, K. L., Selby, T. L., Tevelev, A., Kim, H. J., O’Maille, P. E., & Tsai, M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80042-8 · Cited by 163

Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia.

Loughran, Ö., Malliri, A., Owens, D., Gallimore, P. H., Stanley, M., Ozanne, B. W., Frame, M. C., & Parkinson, E. K. (1996) · PubMed · Cited by 143

Physical Interaction of Mammalian CDC37 with CDK4

Dai, K., Kobayashi, R., & Beach, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22030 · Cited by 134

Induction of senescence in human malignant glioma cells by p16INK4A

Uhrbom, L., Nistér, M., & Westermark, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201227 · Cited by 133

Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts.

Vogt, M., Haggblom, C., Yeargin, J., Christiansen-Weber, T. A., & Haas, M. (1998) · PubMed · Cited by 124

Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins

Musgrove, E. A., Swarbrick, A., Lee, C. S. L., Cornish, A. L., & Sutherland, R. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1812 · Cited by 123

Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.

Goubin, F., & Ducommun, B. (1995) · PubMed · Cited by 120

Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.

Guan, K., Jenkins, C. W., Li, Y., O'Keefe, C., Noh, S. J., Wu, X., Zariwala, M. A., Matera, A. G., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.57 · Cited by 117

Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.

Lukáš, J., Bártková, J., Welcker, M., PETERSEN, O. W., Peters, G., Strauss, M., & Bartek, J. J. (1995) · PubMed · Cited by 115

老化ヒト二倍体線維芽細胞におけるG1サイクリン調節の変化 不活性サイクリンE‐Cdk2及びサイクリンD1‐Cdk2複合体

Dulic, Drullinger, L. F., Lees, E., Reed, S. I., & Stein, G. H. (1993) · Cited by 115

A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis

Elledge, S. J., Winston, J. T., & Harper, J. W. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10030-1 · Cited by 114

Requirement of Cyclin E-Cdk2 Inhibition in p16 INK4a -Mediated Growth Suppression

Jiang, H. N., Chou, H. S., & Zhu, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5284 · Cited by 113

Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities

Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111

Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.

Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J., Tavtigian, S. V., Cannon‐Albright, L., & Kamb, A. (1995) · PubMed · Cited by 103

Differential CDK-inhibitor gene expression in aging human diploid fibroblasts

Wong, H., & Riabowol, K. T. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)00025-9 · Cited by 101

Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells

Mahony, D., Parry, D. A. D., & Lees, E. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201570 · Cited by 99

Structure of the cyclin-dependent kinase inhibitor p19Ink4d

Luh, F. Y., Archer, S. J., Domaille, P. J., Smith, B. O., Owen, D., Brotherton, D. H., Raine, A. R. C., Xu, X., Brizuela, L., Brenner, S. L., et al. (1997) · Nature · doi:10.1038/40202 · Cited by 97

Interaction between Cdc37 and Cdk4 in human cells

Lamphere, L., Fiore, F., Xu, X., Brizuela, L., Keezer, S. M., Sardet, C., Draetta, G. F., & Gyuris, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201036 · Cited by 92

Crystal structure of the CDK4/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16INK4 mutations

Venkataramani, R. N., Swaminathan, K., & Marmorstein, R. (1998) · Nature Structural Biology · doi:10.1038/nsb0198-74 · Cited by 89

p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.

Fotedar, R., FITZGERALD, P. J., Rousselle, T., Cannella, D., Dorée, M., Messier, H., & Fotedar, A. (1996) · PubMed · Cited by 89

Abundance and subcellular localisation of cyclin D3 in human tumours

Bártková, J., Zemanova, M., & Bártek, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960126)65:3 · Cited by 61

Biochemical Characterization of p16 - and p18-containing Complexes in Human Cell Lines

Ragione, F. D., Russo, G. L., Oliva, A., Mercurio, C., Mastropietro, S., Pietra, V. D., & Zappia, V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15942 · Cited by 56

Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases

Adachi, M., Roussel, M. F., Havenith, K., & Sherr, C. J. (1997) · Blood · doi:10.1182/blood.v90.1.126 · Cited by 51

Cyclin‐Dependent Kinase‐2 (Cdk2) Forms an Inactive Complex with Cyclin D1 Since Cdk2 Associated with Cyclin D1 is Not Phosphorylated by Cdk7–Cyclin‐H

Higashi, H., Suzuki‐Takahashi, I., Saitoh, S., Segawa, K., Taya, Y., Okuyama, A., Nishimura, S., & Kitagawa, M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0460k.x · Cited by 35

Ankyrin for clues about the function 0fp16INK4a

McDonald, N. Q., & Peters, G. G. (1998) · Nature Structural Biology · doi:10.1038/nsb0298-85 · Cited by 11

CDK inhibitors: positive and negative regulators of G1-phase progression

Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115

Treating cancer with selective CDK4/6 inhibitors

O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 918

Targeting CDK4 and CDK6 in cancer

Goel, S., Bergholz, J. S., & Zhao, J. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00456-3 · Cited by 565

Proliferation of cancer cells despite CDK2 inhibition

Tetsu, O., & McCormick, F. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 472

Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a

Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 125

Biochemical Characterization of p16 - and p18-containing Complexes in Human Cell Lines

Ragione, F. D., Russo, G. L., Oliva, A., Mercurio, C., Mastropietro, S., Pietra, V. D., & Zappia, V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15942 · Cited by 56

Requirement of Cyclin E-Cdk2 Inhibition in p16 INK4a -Mediated Growth Suppression

Jiang, H. N., Chou, H. S., & Zhu, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5284 · Cited by 113

Regulation of CDK7–Carboxyl-Terminal Domain Kinase Activity by the Tumor Suppressor p16INK4A Contributes to Cell Cycle Regulation

Nishiwaki, E., Turner, S. L., Harju-Baker, S., Miyazaki, S., Kashiwagi, M., Koh, J., & Serizawa, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7726-7734.2000 · Cited by 29

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

Parry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174